1. Home
  2. VFS vs IBRX Comparison

VFS vs IBRX Comparison

Compare VFS & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VinFast Auto Ltd.

VFS

VinFast Auto Ltd.

N/A

Current Price

$3.09

Market Cap

7.3B

Sector

Finance

ML Signal

N/A

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

N/A

Current Price

$10.49

Market Cap

8.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VFS
IBRX
Founded
2017
2014
Country
Vietnam
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
8.2B
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
VFS
IBRX
Price
$3.09
$10.49
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$6.07
★ $12.75
AVG Volume (30 Days)
352.2K
★ 10.5M
Earning Date
11-20-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.71
EPS
★ N/A
N/A
Revenue
N/A
★ $113,288,000.00
Revenue This Year
$57.91
$99.26
Revenue Next Year
$43.72
$101.32
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 668.31
52 Week Low
$2.78
$1.95
52 Week High
$5.29
$12.43

Technical Indicators

Market Signals
Indicator
VFS
IBRX
Relative Strength Index (RSI) 46.17 69.13
Support Level $3.00 $6.68
Resistance Level $3.27 $12.43
Average True Range (ATR) 0.09 0.59
MACD -0.01 0.16
Stochastic Oscillator 15.05 90.04

Price Performance

Historical Comparison
VFS
IBRX

About VFS VinFast Auto Ltd.

VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

Share on Social Networks: